Litcius/Paper detail

Evaluation of the long-term variability of macular OCT/OCTA and visual field parameters

Jo‐Hsuan Wu, Sasan Moghimi, Takashi Nishida, Evan Walker, Alireza Kamalipour, Elizabeth Li, Golnoush Mahmoudinezhad, Linda M. Zangwill, Robert N. Weinreb

2022British Journal of Ophthalmology19 citationsDOIOpen Access PDF

Abstract

BACKGROUND/AIMS: To assess the long-term variability of macular optical coherence tomography (OCT)/OCT angiography (OCTA) and visual field (VF) parameters. METHODS: Healthy and glaucoma eyes with ≥1-year follow-up were included. 24-2 VF and macular OCT/OCTA parameters, including VF mean deviation (MD), whole-image vessel density (wiVD) and ganglion cell complex thickness (wiGCC) were analysed. Intraclass correlation coefficient (ICC), root mean squared error (RMSE), within-subject test-retest SD (Sw) and test-retest variability were calculated for stable eye cohort (max follow-up=1.5 years). Rates of change and RMSE were evaluated in the extended cohort including all eyes (unlimited follow-up). RESULTS: From a total of 230 eyes (150 participants; age=67.7 years), 86 eyes (37%, 62 participants) were stable. In stable eyes, OCT parameters showed the highest mean (95%) ICC (wiGCC=0.99 (0.99, 0.99)), followed by VF (VF MD=0.91 (0.88, 0.93)) and OCTA (wiVD=0.82 (0.75, 0.87)). RMSE and Sw for VF MD were 0.92 dB and 0.81 dB, respectively, for wiVD were 1.64% and 1.48%, respectively, and for wiGCC, 0.91 µm and 0.78 µm, respectively. The long-term test-rest variability of VF MD, wiVD and wiGCC was 2.2 dB, 4.1% and 2.2 µm, respectively. In the extended cohort (mean follow-up=3.0 years), all parameters had significant rates of change (p<0.001), and compared with the stable cohort, only slightly higher RMSE (VF MD=1.07 dB; wiGCC=2.03 µm; wiVD=2.57%) were found. CONCLUSIONS: VF and macular OCT/OCTA, particularly OCT parameters, showed small long-term variability in all eyes, including stable ones, supporting the use of these instruments in glaucoma follow-up. Changes in macular VD and GCC greater than 4%-5% and 2 µm, respectively, indicate possible progression. TRIAL REGISTRATION NUMBER: NCT00221897.

Topics & Concepts

MedicineIntraclass correlationOphthalmologyCohortCoefficient of variationOptical coherence tomographyNuclear medicineMathematicsInternal medicineStatisticsClinical psychologyPsychometricsRetinal Diseases and TreatmentsGlaucoma and retinal disordersOptical Coherence Tomography Applications